Ghostwriting: Research Misconduct, Plagiarism, or Fool's Gold? - 23/03/12
Doi : 10.1016/j.amjmed.2011.07.015
Xavier Bosch, MD, PhD a, ⁎ 
, Joseph S. Ross, MD, MHS b
, Joseph S. Ross, MD, MHS b a Department of Internal Medicine, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques, August Pi i Sunyer, Barcelona, Spain
b Section of General Internal Medicine, Department of Medicine, Yale University School of Medicine and Center for Outcomes, Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn
Requests for reprints should be addressed to Xavier Bosch, MD, PhD, Department of Internal Medicine, Hospital Clínic, University of Barcelona, Villarroel 170, 08036-Barcelona, Spain
Le texte complet de cet article est disponible en PDF.
Plan
| Funding: This project was not directly supported by any external grants or funds. Dr Ross is currently supported by the National Institute on Aging (K08AG032886) and the American Federation of Aging Research through the Paul B. Beeson Career Development Award Program, as well as by a research grant from Medtronic, Inc. |
|
| Conflict of Interest: Dr Bosch has no conflicts of interest to disclose. Dr Ross was previously a paid consultant at the request of plaintiffs in litigation against Merck and Co, Inc, related to rofecoxib in the United States; is currently an unpaid consultant at the request of plaintiffs in litigation against Pfizer, Inc, related to gabapentin in the United States; and is a member of the scientific advisory board for FAIR Health, Inc, in the United States. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
© 2012
Elsevier Inc. Tous droits réservés.
Vol 125 - N° 4
P. 324-326 - avril 2012 Retour au numéro
Article précédent
- A New Disease: Bicuspid Aortic Valve Aortopathy Syndrome
- Vincent L. Sorrell, Eliza Panczyk, Joseph S. Alpert
- B-cell-depleting Therapy in Systemic Lupus Erythematosus
- Manuel Ramos-Casals, Iñaki Sanz, Xavier Bosch, John H. Stone, Munther A. Khamashta
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?